CDK12/13 inhibition in ovarian cancer cell lines

被引：0
|
作者：
Fiegl, H. [1 ]
Hovdar, L. [1 ]
Handle, F. [2 ]
Santer, F. [3 ]
Tsibulak, I [1 ]
Wieser, V [1 ]
Ausserlechner, M. J. [4 ]
Schnaiter, S. [5 ]
Zeimet, A. G. [1 ]
Marth, C. [1 ]
机构：
[1] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria
[2] Med Univ Innsbruck, Inst Pathol Neuropathol & Mol Pathol, Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Urol, Innsbruck, Austria
[4] Med Univ Innsbruck, Dept Pediat 1, Innsbruck, Austria
[5] Med Univ Innsbruck, Inst Human Genet, Innsbruck, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 04期
关键词：
REPAIR;
D O I：
10.1055/s-0043-1766400
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
009
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [41] Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
    Zhang, Tinghu
    Kwiatkowski, Nicholas
    Olson, Calla M.
    Dixon-Clarke, Sarah E.
    Abraham, Brian J.
    Greifenberg, Ann K.
    Ficarro, Scott B.
    Elkins, Jonathan M.
    Liang, Yanke
    Hannett, Nancy M.
    Manz, Theresa
    Hao, Mingfeng
    Bartkowiak, Bartlomiej
    Greenleaf, Arno L.
    Marto, Jarrod A.
    Geyer, Matthias
    Bullock, Alex N.
    Young, Richard A.
    Gray, Nathanael S.
    NATURE CHEMICAL BIOLOGY, 2016, 12 (10) : 876 - +
  • [42] Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
    Tinghu Zhang
    Nicholas Kwiatkowski
    Calla M Olson
    Sarah E Dixon-Clarke
    Brian J Abraham
    Ann K Greifenberg
    Scott B Ficarro
    Jonathan M Elkins
    Yanke Liang
    Nancy M Hannett
    Theresa Manz
    Mingfeng Hao
    Bartlomiej Bartkowiak
    Arno L Greenleaf
    Jarrod A Marto
    Matthias Geyer
    Alex N Bullock
    Richard A Young
    Nathanael S Gray
    Nature Chemical Biology, 2016, 12 : 876 - 884
  • [43] CDK12: A Potent Target and Biomarker for Human Cancer Therapy
    Liang, Shujing
    Hu, Lifang
    Wu, Zixiang
    Chen, Zhihao
    Liu, Shuyu
    Xu, Xia
    Qian, Airong
    CELLS, 2020, 9 (06) : 1 - 15
  • [44] Analysis of CDK12 alterations in a pan-cancer database
    Pan, Elizabeth
    Cabal, Angelo
    Javier-DesLoges, Juan
    Patel, Devin
    Panian, Justine
    Lee, Suzanna
    Shaya, Justin
    Nonato, Taylor
    Xu, Xiaojun
    Stewart, Tyler
    Rose, Brent
    Shabaik, Ahmed
    Cohen, Ezra
    Kurzrock, Razelle
    Tamayo, Pablo
    McKay, Rana R.
    CANCER MEDICINE, 2022, 11 (03): : 753 - 763
  • [45] Inhibition of CDK12 elevates cancer cell dependence on P-TEFb by stimulation of RNA polymerase II pause release
    Wang, Zhijia
    Himanen, Samu V.
    Haikala, Heidi M.
    Friedel, Caroline C.
    Vihervaara, Anniina
    Barboric, Matjaz
    NUCLEIC ACIDS RESEARCH, 2023, 51 (20) : 10970 - 10991
  • [46] Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
    Dieter, Sebastian M.
    Siegl, Christine
    Codo, Paula L.
    Huerta, Mario
    Ostermann-Parucha, Anna L.
    Schulz, Erik
    Zowada, Martina K.
    Martin, Sylvia
    Laaber, Karin
    Nowrouzi, Ali
    Blatter, Mona
    Kreth, Sina
    Westermann, Frank
    Benner, Axel
    Uhrig, Ulrike
    Putzker, Kerstin
    Lewis, Joe
    Haegebarth, Andrea
    Mumberg, Dominik
    Holton, Simon J.
    Weiske, Joerg
    Toepper, Lena-Marit
    Scheib, Ulrike
    Siemeister, Gerhard
    Ball, Claudia R.
    Kuster, Bernhard
    Stoehr, Gabriele
    Hahne, Hannes
    Johannes, Sarah
    Lange, Martin
    Herbst, Friederike
    Glimm, Hanno
    CELL REPORTS, 2021, 36 (03):
  • [47] Induction of BRCAness in Triple-Negative Breast Cancer by a CDK12/13 Inhibitor Improves Chemotherapy
    Hopkins, Jessica L.
    Zou, Lee
    CANCER CELL, 2019, 36 (05) : 461 - 463
  • [48] CDK12/13 INHIBITOR SR-4835 IS ACTIVE IN TRIPLE-NEGATIVE BREAST CANCER
    不详
    CANCER DISCOVERY, 2019, 9 (12) : 1644 - 1644
  • [49] The emerging roles of CDK12 in tumorigenesis
    Paculova, Hana
    Kohoutek, Jiri
    CELL DIVISION, 2017, 12
  • [50] Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium
    Greenleaf, Arno L.
    TRANSCRIPTION-AUSTIN, 2019, 10 (02): : 91 - 110
12345